GMDA News and Press, Gamida Cell Ltd. From 06/25/19

Gainers:  Pyxus International (NYSE: PYX ) +28% . Allergan (NYSE: AGN ) +26% . ENDRA Life Sciences (NASDAQ: NDRA ) +23% . Pier 1 Imports (NYSE: PIR ) +18% . Rafael Holdings (NYSEMKT: RFL ) +16% . Riot Blockchain (NASDAQ: RIOT ) +15% . Vislink Technologies (NASDAQ: VISL ) +15% ....

Tel Aviv, Israel, June 25, 2019 (GLOBE NEWSWIRE) --   Elbit Imaging Ltd. (TASE, UTC UC: EMITF) (“ Elbit ” or the “ Company ”) announced today that on June 24, 2019, Gamida Cell Ltd. (Nasdaq: GMDA) (“ Gamida ”), an indirect shareholding of ...

Gamida Cell (NASDAQ: GMDA ) is 9.7% lower on a registration to offer $34.7M worth of shares . More news on: Gamida Cell Ltd., Healthcare stocks news, Stocks on the move, Read more ...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the launch of a proposed follow-on public offering of approximately $30.0 million of its ordinary shares. In addition, Gamida Cell expects to grant the underwriters a 30-day option to purcha...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, and Lonza (SWX: LONN), an integrated healthcare solutions provider, today announced that the companies have entered into a strategic manufacturing agreement. The agreement provides for the future commercial ...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the appointment of Tracey Lodie, Ph.D., as chief scientific officer. Dr. Lodie will be responsible for setting the scientific strategy, synthetic biology and priorities for Gamida Cell, as we...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that two presentations on omidubicel 1 (formerly known as NiCord ® ), an investigational advanced cell therapy in Phase 3 clinical development designed to enhance the life-saving benefi...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that its previously scheduled Annual Meeting of Stockholders will be webcast on Tuesday, June 4, 2019, at 10:00 a.m. ET (5:00 p.m. Israel daylight time) at the offices of the company located ...

Gamida Cell Ltd. (GMDA) Q1 2019 Earnings Conference Call May 07, 2019, 08:30 ET Company Participants Julian Adams - CEO Ronit Simantov - Chief Medical Officer Shai Lankry - CFO Thomas Klima - Chief Commercial Officer Conference Call Participants Gregory Renza - RBC Capita...

Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming healthcare conferences taking place in New York City during May. On Thursday, May 16, 2019, members of Gamida Cell’s management te...